Summary of COVID-19 medicines guidance: Learning disabilities

Abigail Scott, Regional Medicines Information Pharmacist, Midlands and East Medicines Advice Service (East site)Published Last updated See all updates

This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities.

Our advice is constantly reviewed as the pandemic situation evolves.

Whilst we have tried to ensure that the information on this page is complete, please report a concern if you feel anything is omitted or inaccurate.

To see our professional guidance summaries for other clinical areas, click here

Advice in this area includes:

NICE: Management of patients with a learning disability, autism or both

Last updated: 17 May 2021

  • This resource contains no information relating to specific medicines.

Change history

  1. Minor change to reflect updated date of resource revision.
  1. Published